Ionis Pharmaceuticals, Inc.
Cancer treatment
Last updated:
Abstract:
In certain embodiments, methods, compounds, and compositions for treating B-cell lymphoma or hepatocellular carcinoma by inhibiting expression of STAT3 mRNA or protein in an animal are provided herein. Such methods, compounds, and compositions are useful to treat, prevent, or ameliorate B-cell lymphoma or hepatocellular carcinoma.
Status:
Grant
Type:
Utility
Filling date:
27 Nov 2017
Issue date:
14 Apr 2020